Naphthyridine compounds which inhibit tyrosine kinase and their

Details Naphthyridine compounds which inhibit tyrosine kinase and their Naphthyridine compounds which inhibit tyrosine kinase and their

1993-07-27

1994-11-15

Ivy, C. Warren

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546122, A61K 3144, C07D47102

Patent

active

053648609

ABSTRACT:
The present invention relates to the derivatives of the formula ##STR1## and their addition salts, and to their use in therapeutics, especially as drugs having antiproliferative properties and affording an effective treatment for diseases such as atherosclerosis, restenosis phenomena or any other pathological condition due to cell proliferation.

REFERENCES:
patent: 4622328 (1986-11-01), Tevlon
patent: 4786642 (1988-11-01), Tevlon

Affiliated with

Also associated with

Rating

Naphthyridine compounds which inhibit tyrosine kinase and their does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Naphthyridine compounds which inhibit tyrosine kinase and their , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthyridine compounds which inhibit tyrosine kinase and their will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1097951